3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase II Trial of Iparomlimab/Tuvonralimab (QL1706) + XELOX in HER2-Negative, Low PD-L1 G/GEJ AdenocarcinomaHER2 Negative; Low PD-L1 Expressing; Unresectable or Metastatic Gastric/Gastroesophageal Junction AdenocarcinomaRecruitingPhase 22026-05-07NCT06932068
Comparison of Radiofrequency Ablation With Concomitant or Staged Treatment for Tributary Varicose VeinsVaricose Veins of Lower LimbNot yet recruitingNot applicable2026-03-03NCT07445425
Effect of Predictive Model on Double-Balloon EnteroscopyDouble-balloon EnteroscopyRecruitingNot applicable2026-01-13NCT07288346